- Preamble [SYSTEM]
- Fund & Investor Interest
- Street Moves
- Solebury Trout Updates
- Market Commentary
- IPO News
- Expert Interactions
- Banker Comments & Notes
- Conference Snippet
- Industry Snippets
- Social Media
- Solebury Trout Talks

Fund & Investor Interest: OrbiMed Alum Maps Biotech Push
Stratome Capital Management (Richard D. Klemm, Ph.D.)
A former OrbiMed Advisors co-portfolio manager is forming his own hedge fund firm.Via his New York-based Stratome Capital, Richard Klemm plans to take long and short positions in the shares of early-stage biotechnology companies. He is aiming to launch in September or October with at least $50 million from a single anchor investor.Klemm plans to hire at least two analysts to work with him. In May, he brought in Janine Krause as chief operating ...